Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
The Quantum Revolution Is Creating New Investor Opportunities Worldwide (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Healthcare Drug Manufacturers - Specialty & Generic
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers... see more

Recent & Breaking News (TSX:CTX)

Crescita Reports First Quarter 2026 Results

Business Wire 9 hours ago

Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings

Business Wire April 22, 2026

Crescita Reports Q4 and Fiscal 2025 Results

Business Wire March 31, 2026

Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium

Business Wire March 16, 2026

Crescita Reports Third Quarter 2025 Results

Business Wire November 5, 2025

Crescita Reports Second Quarter 2025 Results

Business Wire August 6, 2025

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Business Wire June 5, 2025

Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®

Business Wire May 23, 2025

Crescita Reports First Quarter 2025 Results

Business Wire May 14, 2025

Crescita Reports Q4 and Fiscal 2024 Results

Business Wire March 18, 2025

Crescita Reports Third Quarter 2024 Results

Business Wire November 6, 2024

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Business Wire September 24, 2024

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Business Wire September 12, 2024

Crescita Reports Second Quarter 2024 Results

Business Wire August 7, 2024

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Business Wire July 22, 2024

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Business Wire July 19, 2024

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device

Business Wire July 17, 2024

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Business Wire June 26, 2024

Crescita to Acquire Strategic Assets of Occy Laboratory

Business Wire June 20, 2024

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Business Wire June 6, 2024

Podcasts